Skip to main content
SpringerLink
Log in

Gliosarcoma Stem Cells: Glial and Mesenchymal Differentiation

  • Chapter
  • First Online:
Stem Cells and Cancer Stem Cells, Volume 2

Part of the book series: Stem Cells and Cancer Stem Cells ((STEM,volume 2))

  • 1332 Accesses

Abstract

Gliosarcoma (GS) is a morphological variant of glioblastoma (GBM), characterized by biphasic glial and sarcomatous compartments. It is not clear whether the mesenchymal metaplasia leading to distinct glial and mesenchymal components in GS is related to the well established mesenchymal gene expression in GBMs, which retain the glial identity. GS stem cells, which preserve the genetic alterations of the original tumors and can differentiate into biphasic mesenchymal and glial components in orthotopic xenografts have been identified. Given the poor prognosis for patients diagnosed with GBM or GS, advances in the understanding of the predictive and prognostic consequences, as well as the mechanisms of activation of mesenchymal programs in these malignancies will likely impact clinical management and outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Actor B, Cobbers JM, Buschges R, Wolter M, Knobbe CB, Lichter P, Reifenberger G, Weber RG (2002) Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. Genes Chromosomes Cancer 34: 416–427

    Article  PubMed  CAS  Google Scholar 

  • Beaumont TL, Kupsky WJ, Barger GR, Sloan AE (2007) Gliosarcoma with multiple extracranial metastases: case report and review of the literature. J Neurooncol 83:39–46

    Article  PubMed  Google Scholar 

  • Biernat W, Aguzzi A, Sure U, Grant JW, Kleihues P, Hegi ME (1995) Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol 54:651–656

    Article  PubMed  CAS  Google Scholar 

  • Boerman RH, Anderl K, Herath J, Borell T, Johnson N, Schaeffer-Klein J, Kirchhof A, Raap AK, Scheithauer BW, Jenkins RB (1996) The glial and mesenchymal elements of gliosarcomas share similar genetic alterations. J Neuropathol Exp Neurol 55:973–981

    Article  PubMed  CAS  Google Scholar 

  • Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, Holland E (2009) Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 4:e7752

    Article  PubMed  Google Scholar 

  • Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, Iavarone A (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318–325

    Article  PubMed  CAS  Google Scholar 

  • Clarke DL, Johansson CB, Wilbertz J, Veress B, Nilsson E, Karlstrom H, Lendahl U, Frisen J (2000) Generalized potential of adult neural stem cells. Science 288:1660–1663

    Article  PubMed  CAS  Google Scholar 

  • deCarvalho AC, Nelson K, Lemke N, Lehman NL, Arbab AS, Kalkanis S, Mikkelsen T (2010) Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo. Stem Cells 28:181–190

    PubMed  CAS  Google Scholar 

  • Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64:6503–6510

    Article  PubMed  CAS  Google Scholar 

  • Galanis E, Buckner JC, Dinapoli RP, Scheithauer BW, Jenkins RB, Wang CH, O’Fallon JR, Farr G Jr (1998) Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results. J Neurosurg 89:425–430

    Article  PubMed  CAS  Google Scholar 

  • Ghods AJ, Irvin D, Liu G, Yuan X, Abdulkadir IR, Tunici P, Konda B, Wachsmann-Hogiu S, Black KL, Yu JS (2007) Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 25:1645–1653

    Article  PubMed  CAS  Google Scholar 

  • Han SJ, Yang I, Ahn BJ, Otero JJ, Tihan T, McDermott MW, Berger MS, Prados MD, Parsa AT (2010a) Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer 116:1358–1366

    Article  PubMed  Google Scholar 

  • Han SJ, Yang I, Otero JJ, Ahn BJ, Tihan T, McDermott MW, Berger MS, Chang SM, Parsa AT (2010b) Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. J Neurosurg 112:990–996

    Article  PubMed  Google Scholar 

  • Hodgson JG, Yeh RF, Ray A, Wang NJ, Smirnov I, Yu M, Hariono S, Silber J, Feiler HS, Gray JW, Spellman PT, Vandenberg SR, Berger MS, James CD (2009) Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. Neurol. Oncol. 11:477–487

    CAS  Google Scholar 

  • Iwasaki K, Kikuchi H, Miyatake S, Kondo S, Oda Y (1992) Establishment of a new cell line derived from a human gliosarcoma. Neurosurgery 30:228–235

    Article  PubMed  CAS  Google Scholar 

  • Kolf CM, Cho E, Tuan RS (2007) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204

    Article  PubMed  Google Scholar 

  • Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391–403

    Article  PubMed  CAS  Google Scholar 

  • Lieberman KA, Fuller CE, Caruso RD, Schelper RL (2001) Postradiation gliosarcoma with osteosarcomatous components. Neuroradiology 43:555–558

    Article  PubMed  CAS  Google Scholar 

  • Louis DN, Ohgaki H, Weistler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system. IARC Press, Lyon, France

    Google Scholar 

  • Lutterbach J, Guttenberger R, Pagenstecher A (2001) Gliosarcoma: a clinical study. Radiother Oncol 61:57–64

    Article  PubMed  CAS  Google Scholar 

  • McKeever PE, Wichman A, Chronwall B, Thomas C, Howard R (1984) Sarcoma arising from a gliosarcoma. South Med J 77:1027–1032

    Article  PubMed  CAS  Google Scholar 

  • McKeever PE, Davenport RD, Shakui P (1991) Patterns of antigenic expression of human glioma cells. Crit Rev Neurobiol 6:119–147

    PubMed  CAS  Google Scholar 

  • Meis JM, Ho KL, Nelson JS (1990) Gliosarcoma: a histologic and immunohistochemical reaffirmation. Mod Pathol 3:19–24

    PubMed  CAS  Google Scholar 

  • Meis JM, Martz KL, Nelson JS (1991) Mixed glioblastoma multiforme and sarcoma. A clinicopathologic study of 26 radiation therapy oncology group cases. Cancer 67:2342–2349

    Article  PubMed  CAS  Google Scholar 

  • Miller CR, Perry A (2007) Glioblastoma. Arch Pathol Lab Med 131:397–406

    PubMed  Google Scholar 

  • Perry JR, Ang LC, Bilbao JM, Muller PJ (1995) Clinicopathologic features of primary and postirradiation cerebral gliosarcoma. Cancer 75:2910–2918

    Article  PubMed  CAS  Google Scholar 

  • Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157–173

    Article  PubMed  CAS  Google Scholar 

  • Reis RM, Konu-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H (2000) Genetic profile of gliosarcomas. Am J Pathol 156:425–432

    Article  PubMed  CAS  Google Scholar 

  • Ricci-Vitiani L, Pallini R, Larocca LM, Lombardi DG, Signore M, Pierconti F, Petrucci G, Montano N, Maira G, De Maria R (2008) Mesenchymal differentiation of glioblastoma stem cells. Cell Death Differ 15:1491–1498

    Article  PubMed  CAS  Google Scholar 

  • Rutka JT, Giblin JR, Hoifodt HK, Dougherty DV, Bell CW, McCulloch JR, Davis RL, Wilson CB, Rosenblum ML (1986) Establishment and characterization of a cell line from a human gliosarcoma. Cancer Res 46:5893–5902

    PubMed  CAS  Google Scholar 

  • Salvati M, Caroli E, Raco A, Giangaspero F, Delfini R, Ferrante L (2005) Gliosarcomas: analysis of 11 cases do two subtypes exist? J Neurooncol 74:59–63

    Article  PubMed  Google Scholar 

  • Schmidek HH, Nielsen SL, Schiller AL, Messer J (1971) Morphological studies of rat brain tumors induced by N-nitrosomethylurea. J. Neurosurg 34:335–340

    Article  PubMed  CAS  Google Scholar 

  • Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial–mesenchymal transitions in development and disease. Cell 139:871–890

    Article  PubMed  CAS  Google Scholar 

  • Tso CL, Shintaku P, Chen J, Liu Q, Liu J, Chen Z, Yoshimoto K, Mischel PS, Cloughesy TF, Liau LM, Nelson SF (2006) Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res 4:607–619

    Article  PubMed  CAS  Google Scholar 

  • Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O’Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110

    Article  PubMed  CAS  Google Scholar 

  • Vescovi AL, Galli R, Reynolds BA (2006) Brain tumour stem cells. Nat. Rev. Cancer 6:425–436

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hermelin Brain Tumor Center, Neurosurgery Research, E&R 3052, Henry Ford Hospital, Detroit, MI, 48202, USA

    Ana C. deCarvalho & Tom Mikkelsen

Authors
  1. Ana C. deCarvalho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tom Mikkelsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ana C. deCarvalho .

Editor information

Editors and Affiliations

  1. , Kean University, Room 213, Library building, Morris Avenue 1000, Union, 07083, New Jersey, USA

    M.A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

deCarvalho, A.C., Mikkelsen, T. (2012). Gliosarcoma Stem Cells: Glial and Mesenchymal Differentiation. In: Hayat, M. (eds) Stem Cells and Cancer Stem Cells, Volume 2. Stem Cells and Cancer Stem Cells, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2016-9_8

Download citation

Publish with us

Policies and ethics

Search

Navigation